nodgoРоссийский журнал детской гематологии и онкологии (РЖДГиО)Russian Journal of Pediatric Hematology and Oncology2311-12672413-5496LTD “Graphica”nodgo-713Research ArticleПРЕСС-РЕЛИЗPRESS RELEASEКраткая информация по инфантильным гемангиомамBrief information on infantile hemangiomasРедакционнаястатьяEditorialArticle20211107202182156157Copyright © Редакционная с., 20212021Редакционная с.Editorial a.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nodgo.org/jour/article/view/713

Инфантильные (младенческие) гемангиомы (ИГ) — доброкачественные сосудистые образования младенческого и раннего детского возраста, обладающие уникальными клиническими и гистопатологическими характеристиками, которые отличают их от других сосудистых образований (например, врожденных гемангиом) или пороков развития. 

инфантильные (младенческие) гемангиомыinfantile hemangiomasReferencesHoeger P.H., Harper J.I., Baselga E., Bonnet D., Boon L.M., Ciofi Degli Atti M., El Hachem M., Oranje A.P., Rubin A.T., Weibel L., Leaute-Labreze C. Treatment of infantile haemangiomas: recommendations of a European expert group. Eur J Pediatr 2015;174(7):855—65. doi: 10.1007/s00431-015-2570-0.Hoeger P.H., Harper J.I., Baselga E., Bonnet D., Boon L.M., Ciofi Degli Atti M., El Hachem M., Oranje A.P., Rubin A.T., Weibel L., Leaute-Labreze C. Treatment of infantile haemangiomas: recommendations of a European expert group. Eur J Pediatr 2015;174(7):855—65. doi: 10.1007/s00431-015-2570-0.Dickison P., Christou E., Wargon O. A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol 2011 ;28(6):663—9. doi: 10.1111/j.1525-1470.2011.01568.x.Dickison P., Christou E., Wargon O. A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol 2011 ;28(6):663—9. doi: 10.1111/j.1525-1470.2011.01568.x.Luu M., Frieden I.J. Haemangioma: clinical course, complications and management. Brit J Dermatol 2013;169(1):20—30. doi: 10.1111/bjd.12436.Luu M., Frieden I.J. Haemangioma: clinical course, complications and management. Brit J Dermatol 2013;169(1):20—30. doi: 10.1111/bjd.12436.Metry D., Frieden I.J., Hess C., Siegel D., Maheshwari M., Baselga E., Chamlin S., Garzon M., Mancini A.J., Powell J., Drolet B.A. Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol 2013;30(1):71—89. doi: 10.1111/j.1525-1470.2012.01879.x.Metry D., Frieden I.J., Hess C., Siegel D., Maheshwari M., Baselga E., Chamlin S., Garzon M., Mancini A.J., Powell J., Drolet B.A. Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol 2013;30(1):71—89. doi: 10.1111/j.1525-1470.2012.01879.x.Munden A., Butschek R., Tom W.L., Marshall J.S., Poeltler D.M., Krohne S.E., Alio A.B., Ritter M., Friedlander D.F., Catanzarite V., Mendoza A., Smith L., Friedlander M., Friedlander S.F. Prospective study of infantile hemangiomas: incidence, clinical characteristics and association with placental anomalies. Brit J Dermatol 2014;170(4):907—13. doi: 10.1111/bjd.12804.Munden A., Butschek R., Tom W.L., Marshall J.S., Poeltler D.M., Krohne S.E., Alio A.B., Ritter M., Friedlander D.F., Catanzarite V., Mendoza A., Smith L., Friedlander M., Friedlander S.F. Prospective study of infantile hemangiomas: incidence, clinical characteristics and association with placental anomalies. Brit J Dermatol 2014;170(4):907—13. doi: 10.1111/bjd.12804.Krowchuk D.P., Frieden I.J., Mancini A.J., Darrow D.H., Blei F., Greene A.K., Annam A., Baker C.N., Frommelt P.C., Hodak A., Pate B.M., Pelletier J.L., Sandrock D., Weinberg S.T., Whelan M.A.; Subcommittee on the management of infantile hemangiomas. Clinical Practice Guideline for the Management of Infantile Hemangiomas. Pediatrics 2019;143(1):e20183475. doi: 10.1542/peds.2018-3475.Krowchuk D.P., Frieden I.J., Mancini A.J., Darrow D.H., Blei F., Greene A.K., Annam A., Baker C.N., Frommelt P.C., Hodak A., Pate B.M., Pelletier J.L., Sandrock D., Weinberg S.T., Whelan M.A.; Subcommittee on the management of infantile hemangiomas. Clinical Practice Guideline for the Management of Infantile Hemangiomas. Pediatrics 2019;143(1):e20183475. doi: 10.1542/peds.2018-3475.Drolet B.A., Frommelt P.C., Chamlin S.L., Haggstrom A., Bauman N.M., Chiu Y.E., Chun R.H., Garzon M.C., Holland K.E., Liberman L., MacLellan-Tobert S., Mancini A.J., Metry D., Puttgen K.B., Seefeldt M., Sidbury R., Ward K.M., Blei F., Baselga E., Cassidy L., Darrow D.H., Joachim S., Kwon E.-K.M., Martin K., Perkins J., Siegel D.H., Boucek R.J., Frieden I.J. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 2013;131(1):128—40. doi: 10.1542/peds.2012-1691.Drolet B.A., Frommelt P.C., Chamlin S.L., Haggstrom A., Bauman N.M., Chiu Y.E., Chun R.H., Garzon M.C., Holland K.E., Liberman L., MacLellan-Tobert S., Mancini A.J., Metry D., Puttgen K.B., Seefeldt M., Sidbury R., Ward K.M., Blei F., Baselga E., Cassidy L., Darrow D.H., Joachim S., Kwon E.-K.M., Martin K., Perkins J., Siegel D.H., Boucek R.J., Frieden I.J. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 2013;131(1):128—40. doi: 10.1542/peds.2012-1691.Filippi L., Cavallaro G., Bagnoli P., DalMonte M., Fiorini P., Donzelli G., Tinelli F., Araimo G., Cristofori G., la Marca G., Della Bona M.L., La Torre A., Fortunato P., Furlanetto S., Osnaghi S., Mosca F. Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives. J Pediatr 2013;163(6):1570—7. doi: 10.1016/j.jpeds.2013.07.049.Filippi L., Cavallaro G., Bagnoli P., DalMonte M., Fiorini P., Donzelli G., Tinelli F., Araimo G., Cristofori G., la Marca G., Della Bona M.L., La Torre A., Fortunato P., Furlanetto S., Osnaghi S., Mosca F. Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives. J Pediatr 2013;163(6):1570—7. doi: 10.1016/j.jpeds.2013.07.049.HaggstromA.N., DroletB .A., Baselga E., Chamlin S. L., Garzon M.C., Horii K.A., Lucky A.W., Mancini A.J., Metry D.W., Newell B., Nopper A.J., Frieden I.J.; Hemangioma Investigator Group. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007;150(3):291—4. doi: 10.1016/j.jpeds.2006.12.003.HaggstromA.N., DroletB .A., Baselga E., Chamlin S. L., Garzon M.C., Horii K.A., Lucky A.W., Mancini A.J., Metry D.W., Newell B., Nopper A.J., Frieden I.J.; Hemangioma Investigator Group. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007;150(3):291—4. doi: 10.1016/j.jpeds.2006.12.003.Drolet B.A., Swanson E.A., Frieden I.J.; Hemangioma Investigator Group. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr 2008;153(5):712—5. doi: 10.1016/j.jpeds.2008.05.043.Drolet B.A., Swanson E.A., Frieden I.J.; Hemangioma Investigator Group. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr 2008;153(5):712—5. doi: 10.1016/j.jpeds.2008.05.043.Smithson S.L., Rademaker M., Adams S., Bade S., Bekhor P., Davidson S., Dore A., Drummond C., Fischer G., Gin A., Grills C., Halbert A., Lokmic Z., McCahon E., Morgan V.A., Murrell D.F., Orchard D., PeningtonA., Purvis D., Relic J., RobertsonS., RobinsonA. J., Scardamaglia L., Su J., Tan S., Wargon O., Warren L., Wong L.-C., Zappala T., Phillips R. Consensus statement for the treatment of infantile haemangiomas with propranolol. Australas J Dermatol 2017;58(2): 155—9. doi: 10.1111/ajd.12600.Smithson S.L., Rademaker M., Adams S., Bade S., Bekhor P., Davidson S., Dore A., Drummond C., Fischer G., Gin A., Grills C., Halbert A., Lokmic Z., McCahon E., Morgan V.A., Murrell D.F., Orchard D., PeningtonA., Purvis D., Relic J., RobertsonS., RobinsonA. J., Scardamaglia L., Su J., Tan S., Wargon O., Warren L., Wong L.-C., Zappala T., Phillips R. Consensus statement for the treatment of infantile haemangiomas with propranolol. Australas J Dermatol 2017;58(2): 155—9. doi: 10.1111/ajd.12600.https://www.ihscoring.com/.https://www.ihscoring.com/.https://grls.rosminzdrav.ru/Default.aspx.https://grls.rosminzdrav.ru/Default.aspx.

The authors declare that there are no conflicts of interest present.